Breaking News Instant updates and real-time market news.

SRPT

Sarepta

$139.53

-6.32 (-4.33%)

06:58
11/06/18
11/06
06:58
11/06/18
06:58

Sarepta price target raised to $188 from $174 at Citi

Citi analyst Joel Beatty raised his price target for Sarepta Therapeutics to $188 following an in-depth analysis of the three Duchenne muscular dystrophy gene therapy programs in development. Based on the analysis, the analyst has a higher conviction that Sarepta will have "significant market share." He keeps a Buy rating on the shares.

  • 06

    Nov

  • 12

    Nov

SRPT Sarepta
$139.53

-6.32 (-4.33%)

10/12/18
BERN
10/12/18
INITIATION
Target $170
BERN
Outperform
Sarepta initiated with an Outperform at Bernstein
Bernstein analyst Vincent Chen initiated Sarepta with an Outperform rating and $170 price target. In a research note to investors, Chen says that a "confluence" of factors make DMD a best case scenario, and very high value, for gene therapy, and while he says manufacturing is not easy, he does not think it will be a problem. Chen says he is "fairly" confident Sarepta can succeed after a deep dive into gene therapy manufacturing.
10/16/18
JMPS
10/16/18
NO CHANGE
Target $270
JMPS
Outperform
JMP likes risk-reward in Sarepta deal for MPS IIIA gene therapy
After Sarepta announced a deal to gain U.S. commercial rights to a potential gene therapy treatment for Mucopolysaccharidosis type IIIA, or MPS IIIA, JMP Securities analyst Liisa A. Bayko said she likes the risk-reward given the relatively limited committed capital and development responsibilities in exchange for full U.S. rights to a late-stage "shot on goal." The analyst, who noted this represents Sarepta's fourth gene therapy deal this year, keeps an Outperform rating and $270 price target on Sarepta shares.
10/25/18
PIPR
10/25/18
NO CHANGE
Target $168
PIPR
Overweight
Sarepta price target lowered to $168 from $189 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff lowered his price target for Sarepta Therapeutics to $168 from $189 and keeps an Overweight rating on the name following the company's Q3 results. Exondys51 sales were in-line at $78.5M in Q3 and management reiterated guidance of $295-$305M for this year, Tenthoff tells investors in a research note. He believes Exondys51 sales of $300M this year "are plateauing" and now forecasts $344M of sales in 2019. The analyst, however, says micro-dystrophin GeneRx is advancing and could treat up to 70% of Duchenne muscular dystrophy boys. He thinks this will erode exon-skipping sales upon approval in 2020.
11/06/18
SBSH
11/06/18
INITIATION
Target $25
SBSH
Sell
Solid Biosciences initiated with a Sell at Citi
Citi analyst Joel Beatty started Solid Biosciences (SLDB) with a Sell rating and $25 price target. The analyst believes the gene therapy agents in clinical development for Duchenne muscular dystrophy by Sarepta (SRPT) and Pfizer (PFE) will leave little market share to Solid Bio's SGT-001. The analyst forecasts Sarepta capturing the largest share of the DMD gene therapy market, followed by Pfizer, and then Solid.

TODAY'S FREE FLY STORIES

LIN

Linde plc

$155.03

1.58 (1.03%)

, APD

Air Products

$160.49

3.34 (2.13%)

07:33
11/16/18
11/16
07:33
11/16/18
07:33
Recommendations
Linde plc, Air Products analyst commentary  »

Linde current price…

LIN

Linde plc

$155.03

1.58 (1.03%)

APD

Air Products

$160.49

3.34 (2.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$80.76

-2.35 (-2.83%)

, AMZN

Amazon.com

$1,620.00

20.84 (1.30%)

07:33
11/16/18
11/16
07:33
11/16/18
07:33
Initiation
Target, Amazon.com, Walmart initiated  »

Target initiated with an…

TGT

Target

$80.76

-2.35 (-2.83%)

AMZN

Amazon.com

$1,620.00

20.84 (1.30%)

WMT

Walmart

$99.62

-1.96 (-1.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 28

    Nov

  • 04

    Dec

  • 03

    Mar

AMAT

Applied Materials

$35.03

1.44 (4.29%)

, LRCX

Lam Research

$146.41

3.62 (2.54%)

07:31
11/16/18
11/16
07:31
11/16/18
07:31
Recommendations
Applied Materials, Lam Research analyst commentary  »

Applied Materials price…

AMAT

Applied Materials

$35.03

1.44 (4.29%)

LRCX

Lam Research

$146.41

3.62 (2.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

VBLT

VBL Therapeutics

$1.14

-0.04 (-3.39%)

07:30
11/16/18
11/16
07:30
11/16/18
07:30
Hot Stocks
VBL Therapeutics reports results from GLOBE study at SNO »

VBL Therapeutics reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 27

    Nov

ONCE

Spark Therapeutics

$38.91

-2.02 (-4.94%)

, QURE

uniQure

$31.00

8.21 (36.02%)

07:30
11/16/18
11/16
07:30
11/16/18
07:30
Upgrade
Spark Therapeutics, uniQure rating change  »

Spark Therapeutics…

ONCE

Spark Therapeutics

$38.91

-2.02 (-4.94%)

QURE

uniQure

$31.00

8.21 (36.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APC

Anadarko

$55.49

1.09 (2.00%)

07:30
11/16/18
11/16
07:30
11/16/18
07:30
Recommendations
Anadarko analyst commentary  »

Anadarko strategic update…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$202.65

5.43 (2.75%)

07:26
11/16/18
11/16
07:26
11/16/18
07:26
Recommendations
Nvidia analyst commentary  »

Nvidia likely to remain…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

AXP

American Express

$109.52

1.75 (1.62%)

, COF

Capital One

$89.21

0.29 (0.33%)

07:26
11/16/18
11/16
07:26
11/16/18
07:26
Recommendations
American Express, Capital One analyst commentary  »

American Express new top…

AXP

American Express

$109.52

1.75 (1.62%)

COF

Capital One

$89.21

0.29 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

BCRX

BioCryst

$7.31

0.31 (4.43%)

07:26
11/16/18
11/16
07:26
11/16/18
07:26
Hot Stocks
BioCryst presents BCX7353 data at ACAAI meeting »

BioCryst presented data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

UBSH

Union Bankshares

$34.26

0.455 (1.35%)

07:25
11/16/18
11/16
07:25
11/16/18
07:25
Recommendations
Union Bankshares analyst commentary  »

Union Bankshares deserves…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JCP

J.C. Penney

$1.37

0.14 (11.38%)

07:24
11/16/18
11/16
07:24
11/16/18
07:24
Downgrade
J.C. Penney rating change  »

J.C. Penney downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

07:23
11/16/18
11/16
07:23
11/16/18
07:23
Recommendations
Nvidia analyst commentary  »

Nvidia price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

TPR

Tapestry

$40.99

-0.11 (-0.27%)

07:23
11/16/18
11/16
07:23
11/16/18
07:23
Recommendations
Tapestry analyst commentary  »

Tapestry price target cut…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

IFF

International Flavors

$142.28

1.01 (0.71%)

07:23
11/16/18
11/16
07:23
11/16/18
07:23
Initiation
International Flavors initiated  »

International Flavors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLOG

GasLog

$20.02

0.17 (0.86%)

, GLOP

GasLog Partners

$24.01

0.16 (0.67%)

07:22
11/16/18
11/16
07:22
11/16/18
07:22
Hot Stocks
GasLog, GasLog Partners to modify IDR »

GasLog (GLOG) and GasLog…

GLOG

GasLog

$20.02

0.17 (0.86%)

GLOP

GasLog Partners

$24.01

0.16 (0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KORS

Michael Kors

$47.22

-0.77 (-1.60%)

07:21
11/16/18
11/16
07:21
11/16/18
07:21
Downgrade
Michael Kors rating change  »

Michael Kors downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$202.65

5.43 (2.75%)

07:21
11/16/18
11/16
07:21
11/16/18
07:21
Recommendations
Nvidia analyst commentary  »

Nvidia price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

GAB

Gabelli Eqty Trust

$6.03

0.02 (0.33%)

07:20
11/16/18
11/16
07:20
11/16/18
07:20
Hot Stocks
Gabelli backs 10% distribution policy, raises Q4 distribution to 19c per share »

The board of The Gabelli…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JCP

J.C. Penney

$1.37

0.14 (11.38%)

07:20
11/16/18
11/16
07:20
11/16/18
07:20
Downgrade
J.C. Penney rating change  »

J.C. Penney downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:20
11/16/18
11/16
07:20
11/16/18
07:20
General news
FX Update: The dollar has traded mixed »

FX Update: The dollar has…

07:20
11/16/18
11/16
07:20
11/16/18
07:20
General news
Canada manufacturing preview »

Canada manufacturing…

AMAT

Applied Materials

$35.03

1.44 (4.29%)

07:19
11/16/18
11/16
07:19
11/16/18
07:19
Recommendations
Applied Materials analyst commentary  »

Citi adds Applied…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPMC

Blueprint Medicines

$52.33

-4.05 (-7.18%)

07:18
11/16/18
11/16
07:18
11/16/18
07:18
Recommendations
Blueprint Medicines analyst commentary  »

Blueprint Medicines data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

CUB

Cubic

$65.71

1.78 (2.78%)

07:18
11/16/18
11/16
07:18
11/16/18
07:18
Recommendations
Cubic analyst commentary  »

Cubic well positioned for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$64.59

1.09 (1.72%)

07:17
11/16/18
11/16
07:17
11/16/18
07:17
Periodicals
Citi says clients are adjusting supply chains due to trade war, CNBC reports »

Citi said their corporate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jan

  • 15

    Apr

  • 13

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.